15 April 2021 in Journal of Biomedical Optics
Smartphone-based imaging (SBI) has been proposed for numerous biomedical applications, many of which use an optical attachment to augment or extend the native device capabilities (Fig. 1). In the past decade, the most common application for SBI has been diagnostic analysis of ex vivo specimens (i.e., point-of-care testing), which has utilized smartphones in a variety of microscopy and microfluidic detection schemes.1 – 4 SBI is also frequently proposed for noninvasive monitoring and diagnosis of externally accessible tissues, particularly in dermatological applications.5 More recently, SBI for minimally invasive procedures and treatment guidance has also been reported, including photodynamic therapy (PDT),6 – 9 endoscopy,10 – 13 in vivo microscopy,14 – 17 and surgery.18 – 22 As ex vivo diagnostic applications have been extensively reviewed elsewhere,1 – 4 this review focuses on SBI systems for real-time tissue imaging applications (i.e., in vivo monitoring, diagnosis, and treatment guidance). However, recent developments in ex vivo diagnostic system designs, which may have relevance in tissue imaging applications are also discussed for comparison and contrast.
15 July 2019 in Expert Review of Molecular Diagnostics
Introduction: Cervical cancer mortality rates remain high in low- and middle-income countries (LMICs) and other medically underserved areas due to challenges with implementation and sustainability of routine screening, accurate diagnosis, and early treatment of preinvasive lesions. Areas covered: In this review, we first discuss the standard of care for cervical cancer screening and diagnosis in high- and low-resource settings, biomarkers that correlate to cervical precancer and cancer, and needs for new tests. We review technologies for screening and diagnosis with a focus on tests that are already in use in LMICs or have the potential to be adapted for use in LMICs. Finally, we provide perspectives on the next five years of technology development for improved cervical cancer screening and diagnosis in LMICs. Expert opinion: Innovation toward improved molecular and imaging tests is needed to enable effective, affordable see-and-treat approaches to detect and treat cervical precancer in a single visit. Current molecular tests remain too complex and/or costly for widespread use. Especially with imaging tests, decision support may improve performance of new technologies.
26 October 2022 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
3 April 2021 in International Journal of Cancer
JFJosé Humberto Tavares Guerreiro Fregnani
José Humberto Tavares Guerreiro Fregnani
+7
31 May 2018 in Cancer Prevention Research
JFJosé Humberto Tavares Guerreiro Fregnani
José Humberto Tavares Guerreiro Fregnani
+8
Cervical cancer is a leading cause of death in underserved areas of Brazil. This prospective randomized trial involved 200 women in southern/central Brazil with abnormal Papanicolaou tests. Participants were randomized by geographic cluster and referred for diagnostic evaluation either at a mobile van upon its scheduled visit to their local community, or at a central hospital. Participants in both arms underwent colposcopy, in vivo microscopy, and cervical biopsies. We compared rates of diagnostic follow-up completion between study arms, and also evaluated the diagnostic performance of in vivo microscopy compared with colposcopy. There was a 23% absolute and 37% relative increase in diagnostic follow-up completion rates for patients referred to the mobile van (102/117, 87%) compared with the central hospital (53/83, 64%; P = 0.0001; risk ratio = 1.37, 95% CI, 1.14–1.63). In 229 cervical sites in 144 patients, colposcopic examination identified sites diagnosed as cervical intraepithelial neoplasia grade 2 or more severe (CIN2+; 85 sites) with a sensitivity of 94% (95% CI, 87%–98%) and specificity of 50% (95% CI, 42%–58%). In vivo microscopy with real-time automated image analysis identified CIN2+ with a sensitivity of 92% (95% CI, 84%–97%) and specificity of 48% (95% CI, 40%–56%). Women referred to the mobile van were more likely to complete their diagnostic follow-up compared with those referred to a central hospital, without compromise in clinical care. In vivo microscopy in a mobile van provides automated diagnostic imaging with sensitivity and specificity similar to colposcopy. Cancer Prev Res; 11(6); 359–70. ©2018 AACR.